Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Clinical Trials in Seattle, Washington

Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma